Pattern of Admitted Cases in Respiratory Intensive Care Unit at Assiut University Hospitals

Sponsor
Assiut University (Other)
Overall Status
Unknown status
CT.gov ID
NCT03296215
Collaborator
(none)
200
18

Study Details

Study Description

Brief Summary

Human health comprises many different states, ranging from perfect health to critical illness, so medical facilities should be able to provide medical assistance tailored to the patient's degree of disease.

The Intensive Care Unit (ICU) serves as a place for monitoring and care of patients with potentially severe physiologic instability requiring technical and/or artificial life support. The level of care in an ICU is greater than that available on the floor or Intermediate Care Unit.

Because of the utilization of expensive resources, ICUs should, in general, be reserved for those patients with reversible medical conditions who have a "reasonable prospect of substantial recovery".

About one third of hospital mortality occurs in critically ill patients in the intensive care unit. On the other hand, critically ill patients are responsible for 10 - 20 % of global hospital costs.

It is well accepted that early appropriate referral of patients to an ICU can significantly reduce early and possibly late mortality in the critically ill.At the same time improper selection of patients for ICU who block ICU beds often limits bed availability in ICUs. This in turn adversely affects the dynamics the whole hospital.

The Respiratory Intensive Care Unit (RICU) is an area that provides closed monitoring and intensive treatment for patients with acute or exacerbated respiratory failure caused by a disease that is primarily respiratory.

Condition or Disease Intervention/Treatment Phase
  • Other: Observational

Study Design

Study Type:
Observational
Anticipated Enrollment :
200 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Pattern of Admitted Cases in Respiratory Intensive Care Unit at Assiut University Hospitals
Anticipated Study Start Date :
Sep 1, 2018
Anticipated Primary Completion Date :
Sep 1, 2019
Anticipated Study Completion Date :
Mar 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Observational

Patterno of admitted cases in Respiratory Intensive Care Unit at Assiut University Hospitals and Outcome

Other: Observational
To determine different patterns of admission and their Outcome

Outcome Measures

Primary Outcome Measures

  1. The purpose of study is determine prognosis of patients admitted in Respiratory Intensive Care Unit at Assiut University Hospitals. [First 24hours of admission.]

    Assessment of Acute Physiology and Health Evaluation II (APHCHE II) score of each admitted case.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 86 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

Patients with the following conditions are candidates for admission to the respiratory

Intensive Care Unit. The following conditions include, but are not limited to:
  1. Acute respiratory failure requiring ventilatory support

  2. Acute pulmonary embolism with haemodynamic instability

  3. Massive haemoptysis

  4. Upper airway obstruction

Exclusion Criteria:
Patients who are generally not appropriate for respiratory ICU admission:
  1. Irreversible brain damage

  2. End stage cardiac, respiratory and liver disease with no options for transplant

  3. Metastatic cancer unresponsive to chemotherapy and/or radiotherapy

  4. Patients with non-traumatic coma leading to a persistent vegetative state (7,8,9,10)

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Assiut University

Investigators

  • Principal Investigator: Mahmoud Badwy, Resident, Assiut University
  • Study Director: Yousef Ahmad, Prof, Assiut University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Mahmoud Badwy, Investigator, Assiut University
ClinicalTrials.gov Identifier:
NCT03296215
Other Study ID Numbers:
  • Mahmoud Badwy2017
First Posted:
Sep 28, 2017
Last Update Posted:
Sep 28, 2017
Last Verified:
Sep 1, 2017
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Sep 28, 2017